Studies approved by the Medical School Ethics Committee.

 

• Analysis of lesion distribution in patients with disseminated nontuberculous mycobacterial disease evaluated by imaging studies
  （Research period： March 15,2024 ～March 14,2029)
• Diagnosis of Amoebic Dysentery Infection
  (Research period: June 23, 2020 – March 31, 2023)
• Acquisition Rate of Antibodies against COVID-19
  (Research period: March 1, 2020 – February 28, 2025)
• Pulmonary Nontuberculous Mycobacterial Disease
  (Research period: January 28, 2020 – March 31, 2021)
• Chronic Respiratory Disease
  (Research period: [xx, 20xx] – October 31, 2023)
• Pulmonary MAC Infection
  (Research period: February 29, 2016 – December 31, 2020)
• Pediatrics
  (Research period: March 7, 2017 – January 31, 2022)
• Invasive Infections
  (Research period: July 4, 2016 – May 31, 2024)
• Drug-Resistant Bacterial Infections
  (Research period: December 5, 2016 – October 31, 2021)
• Vancomycin-Resistant Enterococcus Infections
  (Research period: July 4, 2016 – May 31, 2021)
• Nontuberculous Mycobacterial Disease
  (Research period: January 18, 2018 – October 31, 2022)
• Appropriate Use of Antimicrobial Agents
  (Research period: January 29, 2018 – March 31, 2023)
• Infection Control
  (Research period: March 30, 2018 – March 31, 2023)
• QuantiFERON Test
  (Research period: October 4, 2018 – September 30, 2023)

Return to the List of
Studies approved by the Medical School Ethics Committee.

Return to the List of
Commitment to Research